Publicité
Publicité
RKDA
Arcadia Biosciences, Inc.
2.66
USDSponsorisé
-0.09
-3.27%
09 janv., 15:59 UTC -5
Fermé
Après-marché
2.75
+0.09
+3.42%
RKDA Rapports sur les bénéfices
Ratio de surprise positive
RKDA a dépassé 22 des 38 dernières estimations.
58%
Prochain rapport
Date du prochain rapport
18 mars 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.43M
/-$0.67
Variation implicite de Q3 25 (Revenue/ EPS)
+9.68%
/-208.06%
Variation implicite de Q4 24 (Revenue/ EPS)
+17.43%
/-77.59%
Arcadia Biosciences, Inc. earnings per share and revenue
On 07 nov. 2025, RKDA reported earnings of 0.62 USD per share (EPS) for Q3 25, beating the estimate of -0.55 USD, resulting in a 212.56% surprise. Revenue reached 1.30 million, compared to an expected 1.94 million, with a -32.82% difference. The market reacted with a -2.17% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analystes forecast an EPS of -0.67 USD, with revenue projected to reach 1.43 million USD, implying an baisse of -208.06% EPS, and hausse of 9.68% in Revenue from the last quarter.
FAQ
What were Arcadia Biosciences, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Arcadia Biosciences, Inc. reported EPS of $0.62, beating estimates by 212.56%, and revenue of $1.30M, -32.82% below expectations.
How did the market react to Arcadia Biosciences, Inc.'s Q3 2025 earnings?
The stock price moved down -2.17%, changed from $3.69 before the earnings release to $3.61 the day after.
When is Arcadia Biosciences, Inc. expected to report next?
The next earning report is scheduled for 18 mars 2026.
What are the forecasts for Arcadia Biosciences, Inc.'s next earnings report?
Based on 3
analystes, Arcadia Biosciences, Inc. is expected to report EPS of -$0.67 and revenue of $1.43M for Q4 2025.
Which companies are reporting earnings today?
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité